Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI): Where we are today
|
|
- Johnathan Parrish
- 5 years ago
- Views:
Transcription
1 Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI): Where we are today Benjamin C. Eloff, Ph.D. Senior Scientific Program Manager Office of the Chief Scientist, FDA
2 The SAFARI Initiative AF ablation techniques and devices developed and refined rapidly Guidelines, consensus statement, AHRQ review published relying on current state of evidence, and noting limited follow-up data and limited generalizability of data. FDA recognizes similar gaps in data generated in premarket studies as discussed in September 2007 panel meeting FDA proposes a project through CSRC to develop a publicprivate partnership (PPP) to identify and fill known gaps in data April 2009, FDA hosts first workshop for SAFARI ACC, HRS, AdvaMed, CSRC, & FDA joined together to lay groundwork for the structure of the SAFARI partnership
3
4 Basic Steps in Developing PPPs with FDA (not comprehensive! not consecutive!) Start with the Public Health Need, SCIENCE! Identify Priorities for multiple stakeholders Identify gaps/avoid duplication e.g. biomarkers: Hold expert workshop, Identify partners etc. Leverage resources/expertise Identify partners: define roles/responsibilities Co-develop: proposals, budgets, timelines etc. Implement joint projects Share data in public domain as quickly as appropriate Some Benefits Industry: Postmarket trial data, Hypothesis generation FDA: Data for guidance development and regulatory mission ACC/HRS: Best Practices, Clinical Data CMS & Payers: Data for reimbursement policy decisions Patients: faster, safer and cheaper medical products!!!!
5 SAFARI Mission To facilitate a national pan-stakeholder collaboration supporting the design, implementation, and maintenance of a logistically feasible registry platform for systematic data collection characterizing the safety and effectiveness of on- and off-label real world atrial fibrillation ablation. The intention of this registry will be to inform the development of reliable knowledge, practice guidelines, and to better inform regulatory processes in relationship to the safety of medical products used in the diagnosis, ablation and subsequent treatment of atrial fibrillation.
6 SAFARI Objectives Establish a transparent, nationwide registry for collecting data related to AF ablation procedures Publicly report the data contained in the registry to inform the public health Specifically, the SAFARI partnership will: 1. Develop a framework for collaboration with participation from multiple stakeholders, resulting in an administrative infrastructure to facilitate joint activities in the study of ablation therapies for AF. 2. Support efforts to bridge the knowledge gaps that exist in the field of AF ablation. 3. Ensure that information resulting from these collaborative efforts is appropriately made available to stakeholders and the public. 4. Inform stakeholders, clinicians, and patients, through joint publications, regulatory guidance documents, workshops, and other educational and outreach efforts, of any potential safety risks associated with AF ablation. 5. Make recommendations on labeling of AF ablation devices, based on available data, and to inform regulatory decision-making. 6. Inform future activities, including clinical trials and the application of ablation therapy to treat AF.
7 Stakeholder Community Industry Payers Government Academia Professional Societies Hospitals Steering Executive Operations Budget Ad hoc Meeting Registry development team Registry implementation team Data quality team Data use & publications team
8 Today s Meeting and Next Steps Establish Steering and modify/implement governance Continue outreach to interested stakeholders Summarize, incorporate, and publish feedback from this meeting Secure funding for pilot registry
9 Thank You Meeting Planning Sana Al-Khatib Muriel Corcoran Ruey Dempsey John Finkle Daniel Frisch Isabelle LeBlanc Kristi Mitchell Kathy Pontzer Jeremy Ruskin Executive Operations Peter Kowey (Co-Chair) Ben Eloff (Co-Chair) Marcia Yaross Hugh Calkins Stephen Hammill Mitchell Krucoff Ellen Pinnow CSRC staff Valarie Morrow Valerie Bailey Eva Hill
Faster, More Efficient Innovation through Better Evidence on Real-World Safety and Effectiveness
Faster, More Efficient Innovation through Better Evidence on Real-World Safety and Effectiveness April 28, 2015 l The Brookings Institution Authors Mark B. McClellan, Senior Fellow and Director of the
More informationReal-World Evidence: A CDRH Perspective
Real-World Evidence: A CDRH Perspective Karen Ulisney, MSN, CRNP Policy Analyst, Clinical Trials Program Office of Device Evaluation CDRH, FDA Case for Quality Forum July 20, 2017 Patients are at the Heart
More informationRegistry of Patient Registries (RoPR) Policies and Procedures
Registry of Patient Registries (RoPR) Policies and Procedures Version 4.0 Task Order No. 7 Contract No. HHSA290200500351 Prepared by: DEcIDE Center Draft Submitted September 2, 2011 This information is
More informationRare Disease Registries
Rare Disease Registries Dr Marcus Klein, Senior Director, Regional Medical Officer J-APAC Anne Fabry Disease Denmark Discussion Topics Evolution and increasing role of Observational Research Genzyme s
More informationFDA Vision for Innovative Surveillance of Orthopedic Implants
FDA Vision for Innovative Surveillance of Orthopedic Implants Danica Marinac-Dabic, MD, PhD Director, CDRH Division of Epidemiology Head, FDA ICOR Initiative Total and Resurfacing Hip Systems: Post-Approval
More informationProfessional Biography
'MIND THE GAP!': HOW SHOULD WE MANAGE THE DIFFERENCE BETWEEN REGULATORY AND REIMBURSEMENT EVIDENCE REQUIREMENTS FOR MEDICAL DEVICES? Nneka Onwudiwe PharmD PhD MBA PRO/PE Regulatory Reviewer Professional
More informationCollaborative Communities: It Really Does Take a Village
Collaborative Communities: It Really Does Take a Village April 25 th Karen Conway, GHX Denise Downing, AORN Ellenmary Martin, Dukal Corp. Terrie Reed, FDA Linda Rouse-O Neill, HIDA Slide 1 Slide 2 2018
More informationPLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS
PLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS In August 2010, the Food and Drug Administration s Center for Devices and Radiological Health (CDRH or the Center) released for public
More informationConfronting the Challenges of Rare Disease:
Confronting the Challenges of Rare Disease: SOLUTIONS ACROSS THE ENTIRE PRODUCT LIFE CYCLE The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients
More informationSIMPLE SOLUTIONS. BIG IMPACT.
SIMPLE SOLUTIONS. BIG IMPACT. SIMPLE SOLUTIONS. BIG IMPACT. QUALITY IMPROVEMENT FOR INSTITUTIONS combines the American College of Cardiology s (ACC) proven quality improvement service solutions and its
More informationBest Practices for emeasure Implementation. Breakout Session #2: Implementation in Office-Based Practice Settings
Best Practices for emeasure Implementation Breakout Session #2: Implementation in Office-Based Practice Settings Track Leaders: Kendra Hanley John Maese, MD Michael Mirro, MD April 26, 2012 emeasure Learning
More informationTopic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015
Topic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015 1. What are the CAP s views on the regulatory oversight of laboratory-developed tests (LDTs)? 2. How are
More informationMULTIPLE SCLEROSIS SCIENTIFIC RESEARCH FOUNDATION (MSSRF) MULTI-CENTRE, COLLABORATIVE TEAM GRANT (Team Grant) PROGRAM GUIDE
MULTIPLE SCLEROSIS SCIENTIFIC RESEARCH FOUNDATION (MSSRF) MULTI-CENTRE, COLLABORATIVE TEAM GRANT (Team Grant) PROGRAM GUIDE Revised April 2017 1. BACKGROUND AND GRANT DESCRIPTION...2 a) What is the MSSRF?...
More informationREQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER 2015 RESEARCH AWARD
REQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER 2015 RESEARCH AWARD APPLICATION DEADLINE: 5:00 pm, Friday, January 23, 2015 NEW DEADLINE PURPOSE The Ming Hsieh
More informationFDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update
FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update Ginger M. Sykes Supervisory Consumer Safety Officer Salt Lake City Resident Post Office of Regulatory Affairs U.S. Food and
More informationInstitute of Medicine Standards for Systematic Reviews
Institute of Medicine Standards for Systematic Reviews Christopher H Schmid Tufts University ILSI 23 January 2012 Phoenix, AZ Disclosures Member of Tufts Evidence-Based Practice Center Member, External
More informationGuidance for Developing Payment Models for COMPASS Collaborative Care Management for Depression and Diabetes and/or Cardiovascular Disease
Guidance for Developing Payment Models for COMPASS Collaborative Care Management for Depression and Diabetes and/or Cardiovascular Disease Introduction Within the COMPASS (Care Of Mental, Physical, And
More informationBONE STRESS INJURIES
BONE STRESS INJURIES 1. NBA & GE HEALTHCARE BACKGROUND AND OVERVIEW 1.1. Collaboration Overview: In June 2015, the NBA and GE Healthcare launched the NBA & GE Healthcare Orthopedics and Sports Medicine
More informationPopulation Health Management Tools and Strategies to Support Care Coordination An InfoMC White Paper April 2016
Population Health Management Tools and Strategies to Support Care Coordination An InfoMC White Paper April 2016 Norris, Susan, Ph.D., Chief Clinical Officer, InfoMC Daniels, Allen S., Ed.D., Clinical Director,
More informationMaking the most of patient registries
Making the most of patient registries Elizabeth Hernberg-Ståhl M.Sc. Stockholm October 15 Late Phase Solutions Europe AB Rare Disease Research Forum- Challenges and Solutions Stockholm KI, February 21,
More informationWorld Accreditation Day Webinar
Welcome to ANSI s World Accreditation Day Webinar PLEASE NOTE: Everyone is MUTED; please send questions via Questions option Presenter Name Title Q&A follows the presentations Thanks for Your Participation
More informationMETHODOLOGY. Transparency. Conflicts of Interest. Multidisciplinary Steering Committee Composition. Evidence Review
METHODOLOGY In order to support the accuracy, integrity and clinical relevance of recommendations from the Women s Preventive Services Initiative, the recommendation development process is based on adaption
More informationNovember 7, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org November 7, 2011 Division of Dockets Management (HFA-305) Food and Drug Administration
More informationClinical Development Process 2017
InterQual Clinical Development Process 2017 InterQual Overview Thousands of people in hospitals, health plans, and government agencies use InterQual evidence-based clinical decision support content to
More informationEP LAB BENCHMARKING WHITEPAPER
EP LAB BENCHMARKING WHITEPAPER C. DeLaughter, MD; K. Heist, MD, PhD; B.Kind, HRSCS in sights EP LAB BENCHMARKING EXPERT PANEL INTRODUCTION C. DeLaughter, MD; K. Heist, MD, PhD; B.Kind, HRSCS In early 2014,
More informationOn April 19, 2007, the National Working Group on
On April 19, 2007, the National Working Group on Evidence-Based Health Care (the Working Group) hosted a consumer forum on the central role patients should play in evidence-based health care (EBH). The
More informationBetter Medical Device Data Yield Improved Care The benefits of a national evaluation system
A fact sheet from Aug 2016 Better Medical Device Data Yield Improved Care The benefits of a national evaluation system Overview The current system for evaluating implanted medical devices provides inadequate
More informationDynaMed Presentation. PhD. of strategic management Medical Library MUMS. Sima Mohazzab Hosseinian
DynaMed Presentation By: PhD. of strategic management Medical Library MUMS No One Company Can Serve More of Your Hospital s Electronic Reference Needs Than EBSCO Library Research MEDLINE with Full Text,
More informationLatham & Watkins Corporate Department
Number 1133 January 27, 2011 Client Alert Latham & Watkins Corporate Department FDA Announces Actions Designed to Improve the 510(k) Premarket Clearance Process Importantly, however, the Agency s identified
More informationStatement for the Record. American College of Physicians. Hearing before the House Energy & Commerce Subcommittee on Health
Statement for the Record American College of Physicians Hearing before the House Energy & Commerce Subcommittee on Health A Permanent Solution to the SGR: The Time Is Now January 21-22, 2015 The American
More informationMedicare s Impact on Cardiology Drugs and Devices During Clinical Research
Medicare s Impact on Cardiology Drugs and Devices During Clinical Research Ryan Meade, JD Meade & Roach, LLP July 15, 2008 Baltimore, Maryland University of Maryland School of Medicine 1 Overview Theme:
More informationLessons from the EMA Patient Registries Initiative
Lessons from the EMA Patient Registries Initiative STAMP Commission Expert Group 8 th June 2018 Presented by Peter Arlett, with contributions from Patricia McGettigan and Jane Moseley Head of Pharmacovigilance
More informationDuke-Margolis Center: Overview And High Priority Projects in Biomedical Innovation and Payment
Duke-Margolis Center: Overview And High Priority Projects in Biomedical Innovation and Payment Gregory Daniel, PhD, MPH Deputy Director, Duke-Margolis Center for Health Policy Clinical Professor, Fuqua
More informationREQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER
REQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER APPLICATION DEADLINE: 5 pm, Monday, January 22, 2018 PURPOSE The Ming Hsieh Institute aims to make USC an international
More informationAlpha-1 Foundation Letter of Intent and Full Application Instructions
Alpha-1 Foundation Letter of Intent and Full Application Instructions 2017-2018 In-Cycle Grants VERSION 2 July 17, 2017 Alpha-1 Foundation 3300 Ponce de Leon Blvd. Coral Gables, FL 33134 TABLE OF CONTENTS
More informationICH Regulators Forum. Dr Peter Arlett EU
Dr Peter Arlett EU International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use In this presentation ICH Regulators Forum: Background ICH Regulators
More informationStarting the Conversation A SWOT, So What, & Now What? Summary, Implications & Next Steps
Starting the Conversation A SWOT, So What, & Now What? Summary, Implications & Next Steps Arthur Slutsky, M.D. ACAHO Research Co-Chair & Vice President Research, St. Michael s Hospital Presentation Overview
More informationAlpha-1 Foundation Letter of Intent Application Instructions
Alpha-1 Foundation Letter of Intent Application Instructions 2015-2016 In-Cycle Grants VERSION 1 June 30, 2015 Alpha-1 Foundation 3300 Ponce de Leon Blvd. Coral Gables, FL 33134 TABLE OF CONTENTS I. Introduction
More informationStrengthening Patient Care: Building an Effective National Medical Device Surveillance System. February 2015
Strengthening Patient Care: Building an Effective National Medical Device Surveillance System February 2015 The Brookings Institution l Washington, DC www.brookings.edu Authors Gregory Daniel Managing
More informationDANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017]
DANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017] A quality of care assessment comparing safety and efficacy of edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in patients
More informationArtificial Intelligence Changes Evidence Based Medicine A Scalable Health White Paper
Artificial Intelligence Changes Evidence Based Medicine A Scalable Health White Paper TABLE OF CONTENT EXECUTIVE SUMMARY...3 UNDERSTANDING EVIDENCE BASED MEDICINE 3 WHY EBM?.....4 EBM IN CLINICAL PRACTICE.....6
More informationApps at the Point Of Care
Apps at the Point Of Care Andrew Freeman, MD, FACC Director of Clinical Cardiology and Operations National Jewish Health Associate Professor of Medicine National Jewish Health and University of Colorado
More information7/7/17. Value and Quality in Health Care. Kevin Shah, MD MBA. Overview of Quality. Define. Measure. Improve
Value and Quality in Health Care Kevin Shah, MD MBA 1 Overview of Quality Define Measure 2 1 Define Health care reform is transitioning financing from volume to value based reimbursement Today Fee for
More informationHIT and Medicaid: Opportunities for States Part I of a three part series on the State Alliance for E-Health E
Reports from the State Alliance for e-healthe HIT and Medicaid: Opportunities for States Part I of a three part series on the State Alliance for E-Health E Friday, June 1, 2007 2:00 pm EDT This event is
More informationCollaboration of the Hybrid AF Patient: Role of Advanced Practice Providers. Jennifer Walker, RN, MSN, ANP-BC UNC Center for Heart and Vascular Care
Collaboration of the Hybrid AF Patient: Role of Advanced Practice Providers Jennifer Walker, RN, MSN, ANP-BC UNC Center for Heart and Vascular Care Conclusions New paradigm has shifted towards team-based
More informationAPLAR- Center of Excellence Evaluation Form
APLAR- Center of Excellence Evaluation Form Name of Reviewer: Name of Center evaluated: Is the Center applying for certification in all three areas? Yes/No If no, choose the area of focus: Research, Training
More informationDefining an Outcome Measures Framework for Global Surgery
Defining an Outcome Measures Framework for Global Surgery Richard Gliklich MD Leffenfeld Professor of Otology and Laryngology, Harvard Medical School Surgeon, Mass Eye and Ear; Massachusetts General Hospital
More informationEuropean Patients Academy on Therapeutic Innovation
European Patients Academy on Therapeutic Innovation http://www.patientsacademy.eu info@patientsacademy.eu The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under
More informationERN Assessment Manual for Applicants
Share. Care. Cure. ERN Assessment Manual for Applicants 3.- Operational Criteria for the Assessment of Networks An initiative of the Version 1.1 April 2016 History of changes Version Date Change Page 1.0
More informationUnderstanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia. Anne Spinewine
Understanding and improving the quality of medication use: Research in Clinical Pharmacy starting from Academia Clinical Pharmacy Research Group (CLIP) Anne Spinewine 1 04.10.2011 WBI- UCL Research activities
More information2017 Oncology Insights
Cardinal Health Specialty Solutions 2017 Oncology Insights Views on Reimbursement, Access and Data from Specialty Physicians Nationwide A message from the President Joe DePinto On behalf of our team at
More informationTerms of Reference: ALS Canada Project Grant Program 2018
Terms of Reference: ALS Canada Project Grant Program 2018 Overview The 2018 Project Grant Program encompasses applications previously designated for Discovery, Bridge or Clinical Management Grant competitions.
More informationMeasure Applications Partnership (MAP)
Measure Applications Partnership (MAP) Uniform Data System for Medical Rehabilitation Annual Conference Aisha Pittman, MPH Senior Program Director National Quality Forum August 9, 2012 Overview MAP Background
More informationOrganizations in Nuclear Medicine Part IV- Others of Importance. Bennett S. Greenspan, MD SNM MWM Orlando, FL January 27, 2012
Organizations in Nuclear Medicine Part IV- Others of Importance Bennett S. Greenspan, MD SNM MWM Orlando, FL January 27, 2012 Organizations in NM What Are They? What Do They Do? Why Should I Care? How
More informationABMS Organizational QI Forum Links QI, Research and Policy Highlights of Keynote Speakers Presentations
ABMS Organizational QI Forum Links QI, Research and Policy Highlights of Keynote Speakers Presentations When quality improvement (QI) is done well, it can improve patient outcomes and inform public policy.
More informationMedicare Part C Medical Coverage Policy
Clinical Trial Services Origination: June 28, 1999 Review Date: April 18, 2018 Next Review: April, 2020 Medicare Part C Medical Coverage Policy DESCRIPTION OF PROCEDURE Clinical trials (or clinical research
More informationRegistries for Evaluating Patient Outcomes: A User s Guide Second Edition
Registries for Evaluating Patient Outcomes: A User s Guide Second Edition Agency for Healthcare Research and Quality Advancing Excellence in Health Care www.ahrq.gov The Effective Health Care Program of
More information- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation
- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation Pharma Committee meeting, 8 March 2018 Background More than
More informationHealth Technology Assessment (HTA) Good Practices & Principles FIFARMA, I. Government s cost containment measures: current status & issues
KeyPointsforDecisionMakers HealthTechnologyAssessment(HTA) refers to the scientific multidisciplinary field that addresses inatransparentandsystematicway theclinical,economic,organizational, social,legal,andethicalimpactsofa
More informationPatient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force
5 May 2017 EMA/180341/2017 Inspections, Human Medicines, Pharmacovigilance and Committees Division Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force EMA Initiative 1.
More informationIntroduction to Coverage Analysis Part 1. Amanda Miller, Training Program Manager Derek McCormick, Operations Manager October 14, 2016
Introduction to Coverage Analysis Part 1 Amanda Miller, Training Program Manager Derek McCormick, Operations Manager October 14, 2016 Faculty Disclosure In compliance with ACCME Guidelines, I hereby declare:
More informationPotential of the use of electronic patient information for clinical research in the pharmaceutical industry
Potential of the use of electronic patient information for clinical research in the pharmaceutical industry The case of the EHR4CR project Mats Sundgren, AstraZeneca Coordinator 1 Outline Problem statement
More information2010 Operational Plan - Project Description. 1
Project 3 Environmental Assessment of NAFTA Responsible Project Manager at the CEC Secretariat Planned Allocation C$150,000 Working Group(s) associated with this work Trade and Environment Working Group
More informationMovember Clinician Scientist Award (CSA)
Movember Clinician Scientist Award (CSA) Part 1: Overview Information Participating Organisation(s) Funding Category Description The Movember Foundation and Prostate Cancer Foundation of Australia Movember
More informationDRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy
European Parliament 2014-2019 Committee on Industry, Research and Energy 2018/0018(COD) 13.4.2018 DRAFT OPINION of the Committee on Industry, Research and Energy for the Committee on the Environment, Public
More informationHealth System Leadership and Improvement Research at KPSC: Care Improvement Research Team (CIRT)
Health System Leadership and Improvement Research at KPSC: Care Improvement Research Team (CIRT) Michael K. Gould, MD, MS Senior Scientist and Leader, Care Improvement Research Team Director for Health
More informationHEALTH TECHNOLOGIES FUND ROUND 3 BRIEFING
HEALTH TECHNOLOGIES FUND ROUND 3 BRIEFING 2018-03-21 AGENDA Program at a Glance Program Objective Project Funding Two Stage Application Process Assessment Process Program Timelines Lessons Learned from
More informationRetrospective Chart Review Studies
Retrospective Chart Review Studies Designed to fulfill requirements for real-world evidence Retrospective chart review studies are often needed in the absence of suitable healthcare databases and/or other
More informationRegistries for Evaluating Patient Outcomes:
Registries for Evaluating Patient Outcomes: An Introduction to the User s Guide Michelle B. Leavy Managing Editor December 17, 2013 Copyright 2013 Quintiles Your Presenter Michelle Leavy, MPH Research
More informationConsensus Recommendations on Rater Training and Certification
Consensus Recommendations on Rater Training and Certification Prepared by: CNS Summit Rater Training and Certification Workgroup Authors: David Daniel, MD Mark Opler, PhD, MBA Alexandria Wise-Rankovic,
More informationCardiac Certification. Achieving excellence beyond accreditation
Cardiac Certification Achieving excellence beyond accreditation Accreditation is just the beginning. 2 When it comes to accreditation, no organization can match The Joint Commission s experience and knowledge.
More informationSCREENING SCOPING ASSESSMENT RECOMMENDATIONS REPORTING MONITORING & EVALUATION
SCREENING SCOPING ASSESSMENT RECOMMENDATIONS REPORTING MONITORING & EVALUATION Screening vs. Scoping FORMALIZATION Screening Project viability Conversations with potential partners Estimated likelihood
More informationRt hon Jeremy Hunt MP Secretary of State for Health and Social Care. Letter by to Dear Jeremy
Health and Social Care Committee House of Commons London SW1A 0AA Tel: 020 7219 6182 Fax 020 7219 5171 Email: hsccom@parliament.uk Website: www.parliament.uk/hsccom Twitter: @CommonsHealth From Dr Sarah
More informationOffice of Surveillance, Epidemiology, and Laboratory Services Epidemiology and Analysis Program Office
Taking a Critical Look at the Evidence Base for Community Health Improvement: The US Preventive Services Task Force and the Task Force on Community Preventive Services Shawna L. Mercer, MSc, PhD, Director
More informationApplication Instructions for PEDSnet Scholars Institutional K12 Award Last Updated:
Application Instructions for PEDSnet Scholars Institutional K12 Award Last Updated: 2018-10-01 1. Eligibility 1A. Institutions The applicant must be a full-time faculty member at one of the following eight
More informationQuality ID #348: HRS-3 Implantable Cardioverter-Defibrillator (ICD) Complications Rate National Quality Strategy Domain: Patient Safety
Quality ID #348: HRS-3 Implantable Cardioverter-Defibrillator (ICD) Complications Rate National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationPharmacy Schools Council. Strategic Plan November PhSC. Pharmacy Schools Council
Pharmacy Schools Council Strategic Plan 2017 2021 November 2017 PhSC Pharmacy Schools Council Executive summary The Pharmacy Schools Council is seeking to engage with all stakeholders to support and enhance
More information1. Introduction, purpose of this Standard Operating Procedure (SOP)
Details Document Type Document name Ref # Version Effective from Review date Owner Prepared by Reviewed by Approved by Superseded documents Relevant regulations/legislation/guidelines/reference Standard
More information1. Introduction, purpose of this Standard Operating Procedure (SOP)
SOP-CTN-001- Clinical Trial Network - General Organisation and Principles European Society of Anaesthesiology Details Document Type Document name Ref # Version Effective from Review date Owner Prepared
More informationEuropean Patients Academy (EUPATI) Update
European Patients Academy (EUPATI) Update EMA meeting with patient/consumer organisations 11 Dec 2013 Maria Mavris EURORDIS // EUPATI WP4 Co-Lead For patient-centric medicines R&D and to contribute to
More information2018 Call for Projects on ALS Research
2018 Call for Projects on ALS Research 2018 AriSLA Call for Research Projects: PROMOTING RESEARCH EXCELLENCE IN THE FIGHT AGAINST ALS Deadline: at 1.00 pm, April 20 th 2018 1. Aims of the 2018 AriSLA Call
More informationWhy do we need an addendum to ICH E6?
Addendum to ICH E6 Hideaki Ui, Ph.D. Inspection Director Office of Non-clinical and Clinical Compliance Pharmaceuticals and Medical Devices Agency, Japan Disclaimer The views and opinions expressed in
More informationJuly 7, Dear Mr. Patel:
Bakul Patel Senior Policy Advisor United States Food and Drug Administration Center for Devices and Radiological Health Division of Dockets Management (HFA-305) 5630 Fishers Lane, Rm. 1061 Rockville, MD
More informationEvaluation at the Innovation Center
Evaluation at the Innovation Center William Shrank M.D. MSHS Director, Rapid Cycle Evaluation Group The Center for Medicare and Medicaid Innovation Centers for Medicare and Medicaid Services The Innovation
More informationQUALITY IN PULMONARY REHABILITATION
QUALITY IN PULMONARY REHABILITATION GERENE BAULDOFF, PHD, RN, FAACVPR THE OHIO STATE UNIVERSITY COLLEGE OF NURSING WHAT IS QUALITY? Simply put, health care quality is getting: the right care to the right
More informationMDEpiNet RAPID Meeting
MDEpiNet RAPID Meeting BUILD, PCORnet & SENTINEL: Background, Data Model and Data Elements Jeffrey Brown, PhD Associate Professor May 25, 2017 1 FDA Sentinel: Background 2007: FDA Amendments Act A mandate
More informationIntroduction Patient-Centered Outcomes Research Institute (PCORI)
2 Introduction The Patient-Centered Outcomes Research Institute (PCORI) is an independent, nonprofit health research organization authorized by the Patient Protection and Affordable Care Act of 2010. Its
More informationSBAR: NCDR Registries Initiation and Feedback Phase
SBAR: NCDR Registries Initiation and Feedback Phase Title: NCDR Registries CECCV-36 Situation: Less than ~76% of TH procedure sites belong to NCDR Registries. Background: Registries ensure evidenced-based
More informationSurvey into the diagnosis, management and treatment of patients with Atrial Fibrillation
CHRIS RUANE MP, PRIMARY CARE CARDIOVASCULAR SOCIETY and ATRIAL FIBRILLATION ASSOCIATION FREEDOM OF INFORMATION REQUEST Survey into the diagnosis, management and treatment of patients with Atrial Fibrillation
More informationPay-for-Performance: Approaches of Professional Societies
Pay-for-Performance: Approaches of Professional Societies CCCF 2011 Damon Scales MD PhD University of Toronto Disclosures 1.I currently hold a New Investigator Award from the Canadian Institutes for Health
More informationESF Peer Review Services
ESF Peer Review Services What does ESF offer? Scope From call preparation to selection and feedback to applicants, any peer review process involves several sequential steps. In this context, ESF can support
More informationImplementing and Improving: Behavioral Health Quality
Implementing and Improving: Behavioral Health Quality National Collaborative for Innovation in Quality Measurement Sarah Hudson Scholle, MPH, DrPH March 21, 2017 Agenda Alignment of measures and accountability
More informationUConn Health Office of Clinical & Translational Research Standard Operating Procedures
Purpose and Applicability: To ensure that a Medicare Coverage Analysis is done by staff in OCTR for all research clinical trials that produce r routine clinical services (RC) to be billed to Medicare and
More informationPatient-Clinician Communication:
Discussion Paper Patient-Clinician Communication: Basic Principles and Expectations Lyn Paget, Paul Han, Susan Nedza, Patricia Kurtz, Eric Racine, Sue Russell, John Santa, Mary Jean Schumann, Joy Simha,
More informationYear in Review ro ils RO ILS
RO ILS RADIATION ONCOLOGY INCIDENT LEARNING SYSTEM Sponsored by ASTRO and AAPM Year in Review 2015 1 ro ils noun \ˈro i(-ə)ls\ Radiation Oncology Incident Learning System; a system to facilitate safer
More informationPathology & Laboratory Medicine Lower Mainland Consolidation Project V3.10
Pathology & Laboratory Medicine Lower Mainland Consolidation Project V3.10 Pathology and Laboratory Medicine and The Patient Care Pathway Laboratory testing is a critical component of the overall patient
More informationContains Nonbinding Recommendations. Draft Not for Implementation
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 Public Notification of Emerging Postmarket Medical Device Signals ( Emerging Signals ) Draft Guidance for Industry
More informationMDUFA Performance Goals and Procedures Process Improvements Pre-Submissions Submission Acceptance Criteria Interactive Review
Page 1 MDUFA Performance Goals and Procedures... 3 I. Process Improvements... 3 A. Pre-Submissions... 3 B. Submission Acceptance Criteria... 4 C. Interactive Review... 5 D. Guidance Document Development...
More informationFocus on Medical Device: A conversation about Case for Quality. September 22, 2017
Focus on Medical Device: A conversation about Case for Quality September 22, 2017 Agenda Welcome and Introductions Why create a Voluntary Program? What is the Voluntary Program? Q&A 2017 Grant Thornton
More informationCommunity Engagement & Research
Community Engagement & Research Donald E. Nease, Jr., M.D Director, Community Engagement and Research, Colorado Clinical and Translational Sciences Institute; Director of Practice Based Research, University
More information